[Guidelines in the management of Helicobacter pylori infection in Japan].
Asaka
Masahiro
M
Department of Gastroenterology, Hokkaido University Graduate School of Medicine.
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000658:Amoxicillin / Q000008:administration & dosage; D017291:Clarithromycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005757:Gastritis, Atrophic / Q000188:drug therapy / Q000382:microbiology; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D007564:Japan; D064747:Lansoprazole; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy; D008829:Microbiology; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives; D010437:Peptic Ulcer / Q000188:drug therapy / Q000382:microbiology; D011127:Polyps / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors; D012955:Societies, Medical; D013274:Stomach Neoplasms / Q000382:microbiology / Q000628:therapy
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole